Volume 20, Number 3—March 2014
Research
Minimal Diversity of Drug-Resistant Mycobacterium tuberculosis Strains, South Africa1
Table 3
Category | Unadjusted hazard ratio | p value | Adjusted hazard ratio | p value |
---|---|---|---|---|
Spoligotype (ST) pattern | Ref | Ref | – | |
ST60 (KZN) | 2.78 | <0.0001 | 0.14 | 0.60 |
ST34 (Québec) | 2.48 | 0.002 | 0.65 | 0.07 |
ST1 (Beijing) | 0.66 | 0.26 | 0.72 | 0.42 |
All other ST types |
Ref |
Ref |
||
DST group: drug-susceptible | Ref | Ref | ||
MDR | 3.37 | <0.0001 | 3.33 | <0.0001 |
XDR |
5.78 |
<0.0001 |
4.68 |
<0.0001 |
Positive sputum smear | 1.32 | 0.20 | ||
Extrapulmonary TB |
1.67 |
0.02 |
||
CD4 count | ||||
<50 cells/mm3 | 2.46 | 0.007 | ||
51–200 cells/mm3 | 1.41 | 0.30 | ||
>200 cells/mm3 |
Ref |
Ref |
– |
|
Recent hospitalization | 2.81 | <0.0001 |
*Ref, referent; KZN, KwaZulu-Natal DST; drug susceptibility testing; MDR, multidrug-resistant, XDR, extensively drug resistant.
†If a patient had differing isolates on the same day, the less resistant of the 2 was used for these analyses. Results did not change when the more resistant isolate was used (data not shown).
1Preliminary results from this study were presented at the American Thoracic Society International Conference, May 15–20, 2009, San Diego, California, USA.
Page created: February 19, 2014
Page updated: February 19, 2014
Page reviewed: February 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.